Organon & Co. (OGN)
13.38
-0.02
(-0.11%)
USD |
NYSE |
Jun 10, 16:00
13.38
0.00 (0.00%)
After-Hours: 16:52
Organon Max Drawdown (5Y) : 82.70% for May 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| May 31, 2026 | 82.70% |
| April 30, 2026 | 82.70% |
| March 31, 2026 | 82.70% |
| February 28, 2026 | 80.86% |
| January 31, 2026 | 80.86% |
| December 31, 2025 | 80.86% |
| Date | Value |
|---|---|
| November 30, 2025 | 80.86% |
| October 31, 2025 | 80.86% |
| September 30, 2025 | 75.78% |
| August 31, 2025 | 75.78% |
| July 31, 2025 | 75.78% |
| June 30, 2025 | 75.78% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Merck & Co., Inc. | 43.45% |
| Eli Lilly & Co. | 34.47% |
| Ligand Pharmaceuticals, Inc. | 72.85% |
| Veradermics, Inc. | -- |
| Johnson & Johnson | 18.44% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -34.31 |
| Beta (5Y) | 1.535 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 63.23% |
| Historical Sharpe Ratio (5Y) | -0.2846 |
| Historical Sortino (5Y) | -0.6232 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 22.62% |